Catalyst Biosciences Earnings Calls

Mar 31, 2025
Release date May 14, 2025
EPS estimate -
EPS actual -$0.0400
Revenue estimate -
Revenue actual 22.058M
Sep 30, 2023
-$0.0400 (20.00%)
Release date Oct 26, 2023
EPS estimate -$0.0500
EPS actual -$0.0400
EPS Surprise 20.00%
Revenue estimate -
Revenue actual -
Jun 30, 2023
Release date Aug 14, 2023
EPS estimate -$0.0700
EPS actual -$0.0700
Revenue estimate -
Revenue actual -
Mar 31, 2023
-$0.110 (-57.14%)
Release date May 15, 2023
EPS estimate -$0.0700
EPS actual -$0.110
EPS Surprise -57.14%
Revenue estimate -
Revenue actual -

Last 4 Quarters for Catalyst Biosciences

Below you can see how CBIO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Mar 31, 2023 Missed
Release date May 15, 2023
Price on release $0.220
EPS estimate -$0.0700
EPS actual -$0.110
EPS surprise -57.14%
Date Price
May 09, 2023 $0.211
May 10, 2023 $0.220
May 11, 2023 $0.226
May 12, 2023 $0.221
May 15, 2023 $0.220
May 16, 2023 $0.230
May 17, 2023 $0.230
May 18, 2023 $0.227
May 19, 2023 $0.232
4 days before 4.22%
4 days after 5.45%
On release day 4.55%
Change in period 9.90%
Jun 30, 2023
Release date Aug 14, 2023
Price on release $0.349
EPS estimate -$0.0700
EPS actual -$0.0700
Date Price
Aug 08, 2023 $0.340
Aug 09, 2023 $0.342
Aug 10, 2023 $0.340
Aug 11, 2023 $0.336
Aug 14, 2023 $0.349
Aug 15, 2023 $0.370
Aug 16, 2023 $0.439
Aug 17, 2023 $0.480
Aug 18, 2023 $0.542
4 days before 2.68%
4 days after 55.31%
On release day 5.99%
Change in period 59.47%
Sep 30, 2023 Beat
Release date Oct 26, 2023
Price on release $0.539
EPS estimate -$0.0500
EPS actual -$0.0400
EPS surprise 20.00%
Date Price
Oct 20, 2023 $0.500
Oct 23, 2023 $0.466
Oct 24, 2023 $0.431
Oct 25, 2023 $0.530
Oct 26, 2023 $0.539
Oct 27, 2023 $0.525
Oct 30, 2023 $0.511
Oct 31, 2023 $0.511
Nov 01, 2023 $0.511
4 days before 7.80%
4 days after -5.14%
On release day -2.56%
Change in period 2.26%
Mar 31, 2025
Release date May 14, 2025
Price on release $0.511
EPS estimate -
EPS actual -$0.0400
Date Price
Dec 08, 2023 $0.511
Dec 11, 2023 $0.511
Dec 12, 2023 $0.511
Dec 13, 2023 $0.511
Dec 14, 2023 $0.511
Jun 17, 2025 $13.27
Jun 18, 2025 $14.62
Jun 20, 2025 $15.00
Jun 23, 2025 $15.30
4 days before 0%
4 days after 2,892.37%
On release day 2,495.35%
Change in period 2,892.37%

Catalyst Biosciences Earnings History

Earnings Calendar

FAQ

What is the CBIO price-to-earnings (P/E) ratio?
CBIO P/E ratio as of Jul 11, 2025 (TTM) is 48.32.

What are Catalyst Biosciences's retained earnings?
On its balance sheet, Catalyst Biosciences reported retained earnings of $22.06 million for the latest quarter ending Mar 31, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT CATALYST BIOSCIENCES INC
Catalyst Biosciences
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD);...
GOLDEN STAR
Ticker Change Signal Date
RYTM
$62.29
39.19% Jun 25
NOV
$12.25
11.67% Jun 04
TENB
$32.20
1.13% Jun 02
G
GTM
$9.57
6.58% Jun 02
TAC
$8.90
28.20% May 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE